On-Demand Webinars

Have a question about our webinars? Check out the Webinar FAQ.

Clinical trials research was forced to evolve and embrace technology in the wake of the COVID-19 pandemic. This unprecedented crisis created a necessary disruption in the use of technology to ...

Watch Now

Throughout the COVID-19 pandemic, we have continually heard what the “new normal” could mean for our work lives, social lives, schools, communities, and our medical system. But what does it ...

Watch Now

Federal mandates for single IRB (sIRB) review of multisite research have ushered in a new era of sIRB oversight. Multisite research funded by NIH, HHS, and other agencies must now ...

Watch Now

In this webinar, Shannon Roznoski, Director of Product Management at Advarra-Forte and Michael Buckley, Manager, CRIT Enterprise Innovation at Memorial Sloan Kettering Cancer Center will discuss their experience as members ...

Watch Now

The unprecedented COVID-19 pandemic has quickly changed how we live and work. This extraordinary situation has resulted in a significant impact on IRB-approved protocols and research yet to go through ...

Watch Now

Luke Gelinas, IRB Chairperson at Advarra, proposes a practical framework for evaluating offers of payment and applies it to case studies to yield guidance on challenging ethical and regulatory issues ...

Watch Now

Cannabis and cannabis-derived products are being used with increasing frequency in both recreational and therapeutic settings. With more widespread use of cannabis, how can data from well-designed clinical research trials ...

Watch Now

Planned emergency research (subject to the 21 CFR 50.24 regulations) is challenging for IRBs to review under any circumstance. Now, in the era of single IRB (sIRB), add in the ...

Watch Now

The fast and dramatic growth in the field of gene therapy is unprecedented, as the US FDA and regulatory agencies of several other countries have begun issuing approvals for licensed ...

Watch Now

In this webinar hosted by Advarra, presenters will share findings, recommendations, and resources from four projects in CTTI’s MCT program: Novel Endpoints, Mobile Technologies, Decentralized Trials, and Stakeholder Perceptions.

Watch Now

Ready for Research Compliance Solutions That Are Altogether Better?

Get Started